Astec LifeSciences has informed that the trading window will remain closed for some of the Designated Persons beyond the declaration of the Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2024 and until further intimation by the Company. The concerned Designated Persons of the Company have accordingly been intimated not to trade in (buy or sell) Equity Shares of the Company during the stated period.
The above information is a part of company’s filings submitted to BSE.